Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Eligibility, dosing, and treatment require evaluation by a licensed provider
All GLP-1 Agonists Should, Theoretically, Cure Alzheimer's Dementia but Dulaglutide Might Be More Effective Than the Others
The body adjusts to GLP-1 receptor agonist activity, and removing that activity abruptly is not the same as a planned discontinuation
Management already raised 2026 guidance to $82.0 to $85.0 billion in revenue and $35.50 to $37.00 in non-GAAP EPS, and the company has beaten estimates four straight quarters, including a 25.88% EPS beat last quarter (see the Q1 2026 8-K)
US$ 28.25
US$ 24.90
US$ 23.19
US$ 26.58
US$ 25.55
US$ 24.02
US$ 27.61
